Description

Zomelis-SG Tablet is a combination medicine composed of two active ingredients, Vildagliptin and Remogliflozin. Vildagliptin belongs to a class of medications called dipeptidyl peptidase-4 (DPP-4) inhibitors, while Remogliflozin is a sodium-glucose co-transporter-2 (SGLT2) inhibitor. This medicine is primarily used in the treatment of type 2 diabetes mellitus. It helps in controlling blood sugar levels by increasing insulin production and reducing glucose production in the liver. Additionally, it also helps in removing excess sugar from the body through urine. It is usually advised to be taken orally with or without food. The dosage and duration of the treatment will depend on the individual’s condition and response to the medication. It is important to note that this medicine should not be used for the treatment of type 1 diabetes or diabetic ketoacidosis. Potential side effects may include low blood sugar levels, urinary tract infections, and occasional gastrointestinal discomfort. Please consult with a medical professional before using this medicine.

Additional information